Transglutaminase as a blood clotting enzyme
No abstract listed.
Mutual adaptation between mouse transglutaminase 4 and its native substrates in the formation of copulatory plug
Cross-linked A alpha.gamma chain hybrids serve as unique markers for fibrinogen polymerized by tissue transglutaminase
Characterization of a clotting protein, isolated from plasma of the freshwater crayfish Pacifastacus leniusculus
Transglutaminase levels in brain and reticuloendothelial cells during allergic encephalomyelitis determined by a radiochemical method
Role of protein transamidation in serotonin-induced proliferation and migration of pulmonary artery smooth muscle cells
Diagnostic and genetic studies on fibrin-stabilizing factor with a new assay based on amine incorporation
Nepsilon-(gamma-glutamyl) lysine] as a potential biomarker in neurological diseases: new detection method and fragmentation pathways
The end product of transglutaminase crosslinking: simultaneous quantitation of [Nepsilon-(gamma-glutamyl) lysine] and lysine by HPLC-MS3
Inhibition of transglutaminase exacerbates polyglutamine-induced neurotoxicity by increasing the aggregation of mutant ataxin-3 in an SCA3 Drosophila model
Thrombin-activatable fibrinolysis inhibitor (TAFI) deficient mice are susceptible to intracerebral thrombosis and ischemic stroke
Chemical and enzymic detection of protein cross-links. Measurement of epsilon-(gamma-glutamyl)lysine in fibrin polymerized by factor XIII
FXIII induced gelation of human fibrinogen--an alternative thiol enhanced, thrombin independent pathway
Sol Sherry Lecture in Thrombosis : research on clot stabilization provides clues for improving thrombolytic therapies
Enzyme-catalysed polymer cross-linking: Biocatalytic tools for chemical biology, materials science and beyond
Hydrolysis of gamma:epsilon isopeptides by cytosolic transglutaminases and by coagulation factor XIIIa.
Blood Clotting Disorders
Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.